Monthly Archive: February, 2017

What are the drugs promising neuroprotection in PD?

This is a follow up to my previous blog post titled The emerging research boosting Parkinson’s disease treatment. That post reviewed breakthroughs in the treatment of Parkinson’s disease (PD). But what are the advances… Continue reading

30 neurological disorders with long ACRONYMS…and their checklists

Many neurological disorders and syndromes have very long and windy names. To bypass these tongue-twisting appellations, neurologists have become adept at coming up with great and catchy acronyms. Many neurological acronyms are very… Continue reading

Is low vitamin D a cause of multiple sclerosis?

Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk Rhead B, Bäärnhielm M, Gianfrancesco M, et al. Neurol Genet 2016; 2:e97. Abstract OBJECTIVE: We sought to estimate the… Continue reading

What is the relationship of pregnancy to myasthenia gravis?

Increased risk for clinical onset of myasthenia gravis during the postpartum period Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekjær H, Verschuuren JJ, Tallaksen CM. Neurology 2016; 87:2139-2145. Abstract OBJECTIVE: To study the risk… Continue reading

Resolving the treatment conundrums of CIDP

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is as complicated to articulate, as it is to manage. CIDP is the result of an inflammatory attack against myelin, the fatty layer that encases large nerves. The damage… Continue reading

40 rare metabolic neurological disorders and their checklists

Metabolic neurological disorders are rare and complex. Their diagnosis requires deep knowledge and long experience. These characteristics make metabolic neurological disorders most amenable to checklists. Below are 40 metabolic neurological disorders which are… Continue reading